Check the latest share price of Sms Pharma, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 12 Jun 2025
NSE
Get live Sms Pharma share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 4.98 % |
3 Month Return | + 35.46 % |
1 Year Return | + 23.19 % |
3 Year Return | + 224.73 % |
5 Year Return | + 395.86 % |
Market Stats | |
Previous Close | ₹257.35 |
Open | ₹257.00 |
Volume | 1.13L |
Upper Circuit | ₹308.80 |
Lower Circuit | ₹205.90 |
Check Sms Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹2,281.46 Cr
Return on Equity (ROE)
9.28
PE Ratio (TTM)
31.5
Return on capital employed (ROCE)
11.22
Industry PE ratio
57.02
Beta (LTM)
1.22
P/B Ratio
2.78
Dividend Yield
0.22
PEG Ratio
13.82
Quarterly Earnings Growth YOY
25.11
EPS (TTM)
5.81
Sector
Pharmaceuticals
Book Value
59.98
Technical Analysis
Bearish
View Technical Analysis
Investing in Sms Pharma is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Sms Pharma or SMSPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Sms Pharma or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Sms Pharma with just a few clicks!
Track how Sms Pharma P/E has moved over time to understand its valuation trends.
Sms Pharma in the last 5 years
Lowest (-163.97x)
June 20, 2023
Today (31.50x)
June 11, 2025
Industry (57.02x)
June 11, 2025
Highest (2093.00x)
November 11, 2022
Today’s Price to Earnings Ratio: 31.50x
Get the annual and quarterly financial summary of Sms Pharma, including revenue, profit, loss and more.
Check stock indices that include Sms Pharma.
View detailed summary of the earnings and dividend history of Sms Pharma.
SMS Pharmaceuticals Ltd’s net profit jumped 17.59% since last year same period to ₹20.32Cr in the Q4 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 11.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.16%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sms Pharma.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 66.26% | 0.00 | |
Foreign Institutions | 0.08% | 0.00 | |
Mutual Funds | 2.43% | 0.00 | |
Retail Investors | 31.22% | 0.00 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Sms Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,281.46 | 79.17% | 0.67 | 49 | 709 | |
NA | 70.22 | 6.86% | 0.78 | 2 | 45 | |
NA | 4,559.12 | 59.94% | 0.52 | -71 | 1,704 | |
NA | 99.49 | 20.16% | 0.55 | 5 | 75 | |
NA | 10.53 | 53.9% | 0.50 | NA | 18 |
Latest news and events in one place to help you make informed investing decisions in Sms Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, 14.1 Cr → 20.32 Cr (in ₹), with an average increase of 16.5% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 175.48 Cr → 249.62 Cr (in ₹), with an average increase of 29.7% per quarter
Best in 3 Years
In the last 3 years, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 3 months, SMSPHARMA stock has moved up by 35.5%
Promoter Holding Up
Promoters have increased holdings from 64.67% to 66.26% in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.9% return, outperforming this stock by 27.7%
MF Holding Down
Mutual Funds have decreased holdings from 2.55% to 2.43% in Mar 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 0.31% to 0.08% in Mar 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 32.47% to 31.22% in Mar 2025 quarter
Organisation | SMS Pharmaceuticals Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
CEO | P Ramesh Babu |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Sms Pharma.
Funds | Holdings | Prev. 5M |
---|---|---|
Quant Small Cap Fund Growth Option Direct Plan | 0.17% | |
Quant Healthcare Fund Direct Growth | 5.29% | |
Bandhan BSE Healthcare Index Fund Direct Growth | 0.06% |
Sms Pharma share price today stands at ₹255.95, Open: ₹257, Previous Close: ₹257.35, High: ₹265, Low: ₹253, 52 Week High: ₹398, 52 Week Low: ₹176.05.
Today's traded volume of Sms Pharma is 1.13L. Which means that 1.13L shares of Sms Pharma were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Sms Pharma is ₹2,281.46 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Sms Pharma’s 52 week high is ₹398 and 52 week low is ₹176.05. The current share price of Sms Pharma is ₹255.95, which is -35.69% down from its 52 week high and 45.38% up from its 52 week low.